Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)

Clinical trial NCT01303328 · COMPLETED

Trial details

NCT number: NCT01303328
Sponsor: Mithra Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Uterine Cervical Neoplasia Cervix Intraepithelial Neoplasia

Start date: 2011-03-01
Primary completion: 2013-02-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.